Registry of Bleeding Risk in Real World Chinese Acute Coronary Syndrome Patients-II

NCT03402711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5500

Last updated 2018-01-18

No results posted yet for this study

Summary

The present study was designed to observe the incidence of bleeding events and characteristics of bleeding and exploratively analyse bleeding related biomarkers and gene polymorphisms in ACS patients undergoing PCI.

Conditions

  • Acute Coronary Syndrome
  • Percutaneous Coronary Intervention
  • Bleeding

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Yundai Chen, MD · The General Hospital of PLA

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2020-04-30
Completion
2021-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03402711 on ClinicalTrials.gov